Oral Oncology
Volume 46, Issue 4 , Pages e25-e26, April 2010

Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: Is doxycycline the missing link?☆

VU University Medical Centre, De Boelelaan 1117, Amsterdam 1081 HV, Netherlands

Received 23 January 2010; received in revised form 4 February 2010; accepted 4 February 2010. published online 02 March 2010.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ In regards to Shen et al., Oral Oncology 2009 Dec 24.

PII: S1368-8375(10)00047-3

doi:10.1016/j.oraloncology.2010.02.003

Oral Oncology
Volume 46, Issue 4 , Pages e25-e26, April 2010

Article Tools